Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent (GENOSS® DES)
Sponsor: Genoss Co., Ltd.
Summary
In this study, the investigators evaluated the effectiveness and safety of using the GENOSS® DES, which has a biodegradable polymer only on the inner wall of the blood vessel, for patients(all-comers) with coronary artery disease who require percutaneous coronary intervention through stent insertion.
Official title: Evaluation of Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent in Routine Clinical Practice: A Prospective, Single-arm, Multicenter, Observational Study (The GENCOMX Registry)
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2022-07-15
Completion Date
2027-12-31
Last Updated
2025-10-06
Healthy Volunteers
No
Interventions
GENOSS® DES Sirolimus Eluting Coronary Stent System
The GENOSS® DES is L-605 cobalt chromium (CoCr) platform with a strut thickness of 70µm Sirolimus drug with concentration of 1.15µg/mm2 Abluminal biodegradable PLA and PLGA polymers.
Locations (1)
Korea University Anam Hospital
Seoul, Seoul, South Korea